Sagimet Biosciences - Series A (SGMT)'s 30-day implied volatility (IV30) was 88.9% at the close on October 30, 2026, up from 84.9% the day before, against a 52-week range of 68.5% to 112.0%. Its 20-day historical volatility was 78.4%.
Data as of October 30, 2026.